CUAMC
LYEL icon

China Universal Asset Management Company’s Lyell Immunopharma LYEL Stock Holding History

China Universal Asset Management Company’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.2K Sell
3,714
-56
-1% -$1.01K ﹤0.01% 458
2026
Q1 		$75.6K Buy
3,770
+313
+9% +$7.32K 0.01% 428
2025
Q4 		$106K Buy
3,457
+90
+3% +$2.01K 0.01% 404
2025
Q3 		$54.7K Buy
3,367
+401
+14% +$4.58K ﹤0.01% 426
2025
Q2 		$26.2K Buy
2,966
+36
+1% +$328 ﹤0.01% 445
2025
Q1 		$31.5K Sell
2,930
-30
-1% -$368 ﹤0.01% 443
2024
Q4 		$37.9K Buy
2,960
+498
+20% +$9.87K ﹤0.01% 463
2024
Q3 		$67.9K Buy
2,462
+964
+64% +$28.3K 0.01% 378
2024
Q2 		$43.4K Sell
1,498
-945
-39% -$45K 0.01% 366
2024
Q1 		$109K Buy
2,443
+986
+68% +$42.2K 0.01% 366
2023
Q4 		$56.5K Buy
1,457
+1,135
+352% +$40.9K 0.01% 360
2023
Q3 		$9.46K Buy
322
+158
+96% +$7.5K ﹤0.01% 349
2023
Q2 		$10.4K Sell
164
-5
-3% -$277 ﹤0.01% 314
2023
Q1 		$7.98K Buy
169
+42
+33% +$2.25K ﹤0.01% 322
2022
Q4 		$8.79K Buy
127
+11
+9% +$1.09K ﹤0.01% 240
2022
Q3 		$17K Buy
+116
New +$15.7K 0.01% 165

Other funds holding LYEL

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

China Universal Asset Management Company's LYEL Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Lyell Immunopharma (LYEL) stake by 1.5% in Q2 2026, selling an estimated $1.01K and leaving 3,714 shares worth $52.2K. The position accounts for ﹤0.01% of the portfolio, ranked #458.

China Universal Asset Management Company first reported a position in LYEL in Q3 2022 and has held it in 16 quarters since. The position peaked at $109K in Q1 2024. 8 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • China Universal Asset Management Company held 3,714 shares of Lyell Immunopharma worth $52.2K as of Q2 2026.
  • China Universal Asset Management Company sold 56 Lyell Immunopharma shares in Q2 2026, an estimated $1.01K.
  • Lyell Immunopharma made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #458 holding.
  • China Universal Asset Management Company first reported a position in Lyell Immunopharma in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Lyell Immunopharma position peaked at $109K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.